(Q42279386)

English

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

scientific article published on June 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cutler NR

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Anders RJ

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jhee SS

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sramek JJ

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Awan NA

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Bultas J

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Lahiri A

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Woroszylska M

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1102-1106

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Circadian rhythms in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Circadian variation of transient myocardial ischemia in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Circadian rhythms and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Efficacy of sustained-release verapamil in chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Comparative Efficacy, Safety and Pharmacokinetics of VErapamil SR vs VErapamil IR in Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

The efficacy and safety of high-dose verapamil and diltiazem in the long-term treatment of stable exertional angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Sustained-release verapamil formulations for treating hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980738-3

7 January 2021

Identifiers

10.1016/S0002-9149(99)80738-3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42279386&oldid=1940964810"